• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

给予三碘甲状腺原氨酸对骨和矿物质代谢血清标志物的急性及早期影响。

Acute and early effects of triiodothyronine administration on serum markers of bone and mineral metabolism.

作者信息

Kobe N, Takamatsu J, Ito M, Sakane S, Ohsawa N

机构信息

First Department of Medicine, Osaka Medical College, Takatsuki, Japan.

出版信息

Endocrine. 1999 Feb;10(1):53-6. doi: 10.1385/ENDO:10:1:53.

DOI:10.1385/ENDO:10:1:53
PMID:10403571
Abstract

There have been few studies on acute changes of bone metabolism in humans by thyroid hormone. This study aimed to examine the effects of triiodothyronine on serum markers of bone and mineral metabolism during a 7-d course of daily 75 microg therapy in 14 normal volunteers by drawing blood on 1, 2, 3, 5, and 7 d of therapy. Serum calcium concentrations did not significantly change during the course of therapy, while serum phosphorus concentrations were significantly (p < 0.05) decreased from 3.21 +/- 0.43 mg/dL (mean +/- SD) to 2.85 +/- 0.46 mg/dL on the 7th d. Serum PTH concentrations were significantly decreased from 339 +/- 116 pg/mL to 316 +/- 29 pg/mL. Serum concentrations of alkali-phosphatase and bone-specific alkali-phosphatase were not significantly changed, but serum osteocalcin concentrations were significantly increased from 5.71 +/- 1.98 mg/dL to 6.73 +/- 2.24 mg/dL. Serum carboxy-terminal propeptide of type I collagen concentrations were significantly decreased from 137.8 +/- 33.7 microg/L to 119.2 +/- 33.6 microg/L. Serum pyridinoline cross-linked telopeptide domain of type I collagen concentrations, a bone resorption marker, were significantly increased from 3.40 +/- 0.77 to 3.87 +/- 1.05 microg/L, and such significant increase was obtained from the 3rd day. The results indicate that some of bone and mineral markers change rapidly in response to triiodothyronine-induced acute thyrotoxicosis, but the manner of change is not the same as that of chronic thyrotoxicosis.

摘要

关于甲状腺激素对人体骨代谢急性变化的研究较少。本研究旨在通过对14名正常志愿者进行为期7天、每日75微克三碘甲状腺原氨酸治疗,并在治疗的第1、2、3、5和7天采血,来检测三碘甲状腺原氨酸对骨和矿物质代谢血清标志物的影响。治疗过程中血清钙浓度无显著变化,而血清磷浓度在第7天从3.21±0.43毫克/分升降至2.85±0.46毫克/分升,显著降低(p<0.05)。血清甲状旁腺激素浓度从339±116皮克/毫升显著降至316±29皮克/毫升。血清碱性磷酸酶和骨特异性碱性磷酸酶浓度无显著变化,但血清骨钙素浓度从5.71±1.98毫克/分升显著增至6.73±2.24毫克/分升。血清I型胶原羧基末端前肽浓度从137.8±33.7微克/升显著降至119.2±33.6微克/升。作为骨吸收标志物的血清I型胶原吡啶啉交联端肽结构域浓度从3.40±0.77微克/升显著增至3.87±1.05微克/升,且从第3天起就出现了这种显著增加。结果表明,一些骨和矿物质标志物会因三碘甲状腺原氨酸诱导的急性甲状腺毒症而迅速变化,但变化方式与慢性甲状腺毒症不同。

相似文献

1
Acute and early effects of triiodothyronine administration on serum markers of bone and mineral metabolism.给予三碘甲状腺原氨酸对骨和矿物质代谢血清标志物的急性及早期影响。
Endocrine. 1999 Feb;10(1):53-6. doi: 10.1385/ENDO:10:1:53.
2
Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.泼尼松龙和骨化三醇短期治疗对正常男性骨与矿物质代谢的影响。
Bone. 1998 Sep;23(3):297-302. doi: 10.1016/s8756-3282(98)00097-0.
3
Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.维持性透析患者长期静脉注射骨化三醇治疗期间骨标志物的变化。
Miner Electrolyte Metab. 1996;22(4):219-23.
4
Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis.抗甲状腺治疗可改善格雷夫斯甲状腺毒症患者的骨骼表现和骨代谢标志物。
Clin Endocrinol (Oxf). 1997 Aug;47(2):215-21. doi: 10.1046/j.1365-2265.1997.2401045.x.
5
Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.类风湿关节炎患者大剂量糖皮质激素脉冲治疗期间骨代谢(标志物)的变化。
Ann Rheum Dis. 1996 May;55(5):288-93. doi: 10.1136/ard.55.5.288.
6
Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.1型前胶原羧基末端前肽(P1CP)和1型胶原羧基末端端肽(1CTP)作为甲状腺疾病中骨代谢的敏感标志物。
Endocr J. 1996 Dec;43(6):701-8. doi: 10.1507/endocrj.43.701.
7
Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.血清胶原合成与降解肽段在透析肾性骨营养不良中的诊断价值
Nephrol Dial Transplant. 1995;10(1):52-8.
8
Influence of brain injury on early posttraumatic bone metabolism.脑损伤对创伤后早期骨代谢的影响。
Crit Care Med. 2005 Feb;33(2):399-406. doi: 10.1097/01.ccm.0000152221.87477.21.
9
A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.一项关于健康荷兰儿童和年轻人骨转换生化参数及维生素D代谢产物的横断面研究。
Horm Res. 2002;57(5-6):170-9. doi: 10.1159/000058378.
10
Effects of short-term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism.短期最大负荷运动对血浆钙、甲状旁腺激素、骨钙素及胶原代谢生化标志物的影响。
Int J Sports Med. 1995 Apr;16(3):145-9. doi: 10.1055/s-2007-972982.

引用本文的文献

1
Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.病例报告:纠正过度左甲状腺素治疗和长期随访后严重骨质疏松症的快速逆转。
Osteoporos Int. 2017 Jul;28(7):2247-2250. doi: 10.1007/s00198-017-3981-8. Epub 2017 Mar 21.
2
Mechanisms of Normalisation of Bone Metabolism during Recovery from Hyperthyroidism: Potential Role for Sclerostin and Parathyroid Hormone.甲状腺功能亢进症恢复过程中骨代谢正常化的机制:硬化蛋白和甲状旁腺激素的潜在作用
Int J Endocrinol. 2015;2015:948384. doi: 10.1155/2015/948384. Epub 2015 Aug 23.

本文引用的文献

1
Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.1型前胶原羧基末端前肽(P1CP)和1型胶原羧基末端端肽(1CTP)作为甲状腺疾病中骨代谢的敏感标志物。
Endocr J. 1996 Dec;43(6):701-8. doi: 10.1507/endocrj.43.701.
2
Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves' disease.与寂静性甲状腺炎或甲状腺功能亢进型格雷夫斯病相比,亚急性甲状腺炎中通过第三代促甲状腺激素检测测定的促甲状腺激素抑制不全情况。
J Clin Endocrinol Metab. 1997 Feb;82(2):616-9. doi: 10.1210/jcem.82.2.3751.
3
Differences in response of thyrotropin to 3,5,3'-triiodothyronine and 3,5,3'-triiodothyroacetic acid in patients with resistance to thyroid hormone.
甲状腺激素抵抗患者中促甲状腺激素对3,5,3'-三碘甲状腺原氨酸和3,5,3'-三碘甲状腺乙酸反应的差异
Thyroid. 1996 Dec;6(6):563-70. doi: 10.1089/thy.1996.6.563.
4
Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats.肠胃外给予帕米膦酸盐可预防大鼠甲状腺激素诱导的骨质流失。
J Bone Miner Res. 1993 Oct;8(10):1255-61. doi: 10.1002/jbmr.5650081014.
5
Markers of bone turnover in hyperthyroidism and the effects of treatment.甲状腺功能亢进症中骨转换标志物及治疗效果
J Clin Endocrinol Metab. 1994 Apr;78(4):955-9. doi: 10.1210/jcem.78.4.8157727.
6
Increased serum levels of carboxyterminal propeptide of type 1 collagen (PICP) in hyperthyroidism.甲状腺功能亢进症患者血清1型胶原羧基末端前肽(PICP)水平升高。
Horm Metab Res. 1994 Jul;26(7):334-7. doi: 10.1055/s-2007-1001698.
7
Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry.双能X线吸收法测定甲状腺功能亢进患者甲状腺功能正常后骨矿物质密度的变化
Thyroid. 1994 Summer;4(2):179-82. doi: 10.1089/thy.1994.4.179.
8
Hyperthyroidism, thyroid hormone therapy, and bone.甲状腺功能亢进、甲状腺激素治疗与骨骼
Thyroid. 1994 Fall;4(3):319-26. doi: 10.1089/thy.1994.4.319.
9
Mineral and bone metabolism in thyroid disease: a review.甲状腺疾病中的矿物质与骨代谢:综述
Q J Med. 1986 Aug;60(232):737-52.
10
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine.亚临床甲状腺功能亢进以及骨密度降低可能是长期使用左甲状腺素抑制垂体 - 甲状腺轴的结果。
Am J Med. 1987 Jun;82(6):1167-70. doi: 10.1016/0002-9343(87)90219-1.